Lundbeck Strengthens CNS Research Through Acquisition of Synaptic

By Business Review Editor

Pharma Deals Review: Vol 2002 Issue 31 (Table of Contents)

Published: 2 Dec-2002

DOI: 10.3833/pdr.v2002.i31.970     ISSN: 1756-7874

Section: Mergers & Acquisitions

Fulltext:

Abstract

Lundbeck entered into an agreement to acquire Synaptic Pharmaceutical for approximately US$121 M in cash...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details